5 results
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors - Normal ... This drug class ... #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Immunosuppression in Transplantation
Induction (I):
 - Basiliximab (Simulect)
 - Alemtuzumab (Campath)
 - Rituximab
 - Anti-Thymocyte Globulin (ATG)
Induction
Cyclosporine (Neoral ... #Medications #Pharmacology ... #Table #Drugs # ... #Maintenance #Management ... #Nephrology #Renal
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Glucagon-like peptide 1; normally ... Ozempic), or daily tablet ... #Summary #DM2 # ... diabetes #endocrinology
Pharmacologic Options for Hypercalcemia Associated with Cancer
Rehydration with NS followed by loop diuretics
 • IV normal
Pharmacologic Options ... diuretics • IV normal ... #medications #management ... #drugs #treatment ... table
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
order for the drug ... to remain stable ... to ensure the drug ... semaglutide #Diabetes #Pharmacology ... #Endocrinology